NPPA Fixes Retail price of 54 formulations, Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, the Government of India, has fixed retail prices for 54 formulations under the Drugs (Prices Control) Order, 2013.
The list of formulations includes Theon Pharmaceuticals/Alkem Laboratories Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/ Torrent Pharmaceutical's Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/Zydus Healthcare's Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/Micro Lab's Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets, Theon Pharmaceuticals/MSN Laboratories' Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets and others.
This comes after in exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the Table herein below as the retail price, exclusive of Goods and Services Tax, if any, about the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets | Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd. | 20.78 |
2 | Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets | Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 19.00 |
3 | Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Zydus Healthcare Ltd. | 20.78 |
4 | Linagliptin, Dapagliflozin, and Metformin Hydrochloride (SR) Tablets | Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Micro Labs Limited | 15.89 |
5 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film-coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s MSN Laboratories Pvt. Ltd. | 19.64 |
6 | Linagliptin, Dapagliflozin and Metformin | Each film coated bilayer tablet contains: Linagliptin 5mg | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Lupin Limited | 20.78 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride (SR) Tablets | Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | ||||
7 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Mankind Pharma Limited | 20.78 |
8 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd. | 20.78 |
9 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 18.00 |
10 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd. | 19.64 |
11 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Zydus Healthcare Ltd. | 19.64 |
12 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s MSN Laboratories Pvt. Ltd. | 18.75 |
13 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd. | 19.64 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
14 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Micro Labs Limited | 15.00 |
15 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Mankind Pharma Limited | 19.64 |
16 | Linagliptin, Dapagliflozin and Metformin Hydrochloride (SR) Tablets | Each film coated bilayer tablet contains: Linagliptin 5mg Dapagliflozin Propanediol Monohydrate USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd. / M/s Lupin Limited | 19.64 |
17 | Glimepiride & Sitagliptin Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 2 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Mankind Pharma Limited | 15.38 |
18 | Glimepiride & Sitagliptin Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 2 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited | 15.38 |
19 | Glimepiride & Sitagliptin Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 1 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Mankind Pharma Limited | 13.70 |
20 | Glimepiride & Sitagliptin Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Glimepiride IP 1mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited | 13.70 |
21 | Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained release) Metformin Hydrochloride IP 500mg (as Sustained Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 13.78 |
22 | Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets | Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained release) Metformin Hydrochloride IP 1000mg (as Sustained Release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd./ M/s Aristo Pharmaceuticals Pvt. Ltd. | 15.27 |
23 | Sitagliptin Phosphate, Metformin | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Primus | 12.86 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride and Glimepiride Tablets | eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg | Remedies Pvt. Ltd. | |||
24 | Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Primus Remedies Pvt. Ltd. | 14.65 |
25 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited | 9.65 |
26 | Bisoprolol Fumarate and Telmisartan Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Limited | 11.21 |
27 | Bictegravir, Emtricitabine & Tenofovir Alafenamide Tablets | Each film coated tablet contains: Bictegravir Sodium eq. to Bictegravir 50mg Emtricitabine IP 200mg Tenofovir Alafenamide Fumarate IP eq. to Tenofovir Alafenamide 25mg | 1 Tablet | M/s Hetero Labs Limited / M/s Emcure Pharmaceuticals Limited | 132.58 |
28 | Omeprazole + Domperidone Tablets | Each gasto-resistant tablet contains: Omeprazole Magnesium BP eq. to Omeprazole 20mg Domperidone IP 10mg | 1 Tablet | M/s Next Wave (India) / M/s Mankind Prime Labs Pvt. Ltd. | 3.85 |
29 | Ceftriaxone and Sulbactam Injection | Each vial contains: Ceftriaxone Sodium IP eq to Ceftriaxone 250mg Sulbactam Sodium IP eq to Sulbactam 125mg | 1 Vial | M/s Zen Pharma (P) Limited / M/s Hetero Healthcare Ltd. | 58.90 |
30 | Ceftriaxone and Sulbactam Injection | Each vial contains: Ceftriaxone Sodium IP eq to Ceftriaxone1000mg Sulbactam Sodium IP eq to Sulbactam 500mg | 1 Vial | M/s Zen Pharma (P) Limited / M/s Hetero Healthcare Ltd. | 143.92 |
31 | Tranexamic Acid and Mefenamic Acid Tablets | Each film coated tablet contains: Tranexamic Acid IP 500mgMefenamic Acid IP 250mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticals Ltd. | 30.43 |
32 | Donepezil Hydrochloride and Memantine Tablets | Each film coated Tablet contains: Donepezil Hydrochloride IP 10mg Memantine IP 10mg | 1 Tablet | M/s Savi Health Science / M/s Alkem Laboratories Ltd. | 19.11 |
33 | Calcium & Vitamins D3 Tablet | Each film coated tablet contains: 1.25g of Calcium Carbonate from an organic source (Oyster shell) eq. to Elemental Calcium 500mg Cholecalciferol IP (Vitamin D3) 500IU (as stabilized form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Sun Pharmaceutical Industries Limited | 7.82 |
34 | Amoxycillin and Potassium Clavulanate Oral Suspension IP | Each 5ml of the reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg | 1 ml | M/s ALPS Communication Pvt. Ltd. / M/s Galpha Laboratories Ltd. | 3.17 |
35 | Calcitriol, Calcium & Zinc Softgel capsule | Each soft Gelatin Capsule contains: Calcium Carbonate IP 500mg eq. to Elemental Calcium 200mg Calcitriol IP 0.25mcg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 7.5mg | 1 Capsule | M/s Titanium Technologies (India) Pvt. Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd. | 15.94 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
36 | Mupirocin and Sucralfate Ointment | Composition: Mupirocin IP 2% w/w Sucralfate IP 7% w/w | 1 gram | M/s Stedman Pharmaceuticals Pvt. Ltd. | 17.05 |
37 | Cefixime & Ofloxacin for Oral Suspension | Each 5ml of the reconstituted suspension contains: Cefixime Trihydrate IP eq. to cefixime Anhydrous 50mg Ofloxacin IP 50mg (This pack contains 20ml of sterile water for reconstitution) | 1 ml | M/s Theon Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 1.90 |
38 | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets | Each film coated tablet contains: Dextromethorphan Hydrobromide IP 10mg Chlorpheniramine Maleate IP 2mg Phenylephrine Hydrochloride IP 5mg | 1 Tablet | M/s J.K. Print Pack (Pharma Division) / M/s Cadila Pharmaceuticals Ltd. | 4.69 |
39 | Telmisartan, Chlorthalidone & Cilnidipine tablets | Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg Cilnidipine IP 10mg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd. / M/s Indchemie Health Specialities Pvt. Ltd. | 14.07 |
40 | Tranexamic Acid Sustained Release Tablets | Each sustained release film coated tablet contains: Tranexamic Acid IP 750mg | 1 Tablet | M/s Macleods Pharmaceuticals Ltd. | 19.09 |
41 | Atorvastatin & Aspirin Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As granules), Aspirin (As Gastro-resistant tablet IP) IP 75mg | 1 Capsule | M/s Unison Pharmaceuticals Pvt. Ltd. | 2.68 |
42 | Itraconazole Capsules 130mg (Supra- Bioavailable Formulation) | Each hard gelatin capsule contains: Itraconazole BP 130mg | 1 Capsule | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd. | 19.73 |
43 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Glenmark Pharmaceuticals Limited | 14.00 |
44 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet Contain: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Glenmark Pharmaceuticals Limited | 15.32 |
45 | Clindamycin & Nicotinamide Gel | Composition: Clindamycin Phosphate IP eq. to Clindamycin 1.0% w/w Nicotinamide IP 4.0% w/w | 1 Gram | M/s Pharma Force Labs / M/s Cadila Pharmaceuticals Ltd. | 5.35 |
46 | Lidocaine & Prilocaine Gel | Composition: Lidocaine IP 2.50% w/w Prilocaine IP 2.50% w/w Sorbic acid IP (as preservative) 0.08% w/w | 1 Gram | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Ra-Vish Wellness Pvt. Ltd. | 11.39 |
47 | Moxifloxacin Hydrochloride & Dexamethasone Eye Drops | Composition: Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP 0.1% w/v | 1 ml | M/s Aurolab | 14.00 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
48 | Metoprolol Succinate Extended Release, Amlodipine & Telmisartan Tablet | Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended release) Amlodipine Besilate IP eq. to Amlodipine 5mg Telmisartan IP 40mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd. | 14.50 |
49 | Escitalopram Oxalate Tablets | Each film coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram 15mg | 1 Tablet | M/s Merril Pharma Pvt. Ltd. / M/s Alkem Laboratories Limited | 12.39 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Telmisartan, Chlorthalidone and Cilnidipine Tablet | Each film-coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10mg Chlorthalidone IP 6 .25mg | 1 Tablet | M/s Corona Remedies Pvt. Ltd. | 7.14 |
2. | Telmisartan and Chlorthalidone Tablet | Each film coated tablet contains: Telmisartan IP 40mg Chlorthalidone IP 6.25mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd. | 7.28 |
3. | Telmisartan and Amlodipine Tablet | Each uncoated bilayered tablet contains: Telmisartan IP 40mg Amlodipine Besilate IP eq. Amlodipine 5mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd. | 7.31 |
4. | Telmisartan and Cilnidipine Tablet | Each film coated tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg | 1 Tablet | M/s Corona Remedies Pvt. Ltd. | 5.90 |
5. | Telmisartan, Hydrochlorothiazide and Amlodipine Tablets | Each uncoated bilayered tablet contains: Telmisartan IP 40mg Hydrochlorothiazide IP 12.5mg Amlodipine Besylate eq. to Amlodipine 5mg | 1 Tablet | M/s Corona Remedies Pvt. Ltd. | 4.50 |
The notice further added
- The manufacturer of the above-mentioned formulations i.e., ―new drug‖ under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
- The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.
- The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The above mentioned retail price applies only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/ marketing companies.
- In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of manufacturer and marketing companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that manufacturer and marketing Companies as specified in corresponding entries in Column (2),(3) and (5) thereof, if any, issued before this notification, stand(s) superseded.
To view the notice click the below link:
https://medicaldialogues.in/pdf_upload/aba40e1cc7fcb1f3bc6943f313d3aec4-241367.pdf
Also Read:NPPA Revises Ceiling Price of FDC Budesonide Plus Formoterol Inhalation
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd